Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

March 13, 2023

Study Completion Date

March 13, 2023

Conditions
AMSAcute Mountain Sickness
Interventions
OTHER

Immediate descent from altitude.

Immediate descent from altitude for severe symptoms or anyone who wished to discontinue their participation in the study.

DRUG

Diphenhydramine

Diphenhydramine was available to counteract any potential extrapyramidal side effects of the study drug. The use of Diphenhydramine for this purpose is well established.

DRUG

Prochlorperazine 10 mg

Subjects in the Prochlorperazine arm were administered 10mg PO Prochlorperazine immediately prior to ascent

Trial Locations (1)

78405

CHRISTUS Health-Texas A&M Spohn Emergency Medicine Residency, Corpus Christi

All Listed Sponsors
lead

CHRISTUS Health

OTHER